Clincosm LogoSign in Get a demo

Diabetes

Showing NaN - NaN of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +301 more
Feb 16, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • placebo
  • Anaheim, California
  • +86 more
Sep 26, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, , liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Anaheim, California
  • +131 more
Aug 25, 2017

Diabetes Trial in Philadelphia (Large Envelope, Priority Mail, Amazon)

Completed
  • Diabetes
  • Large Envelope
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jun 26, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • Hamilton, Alabama
  • +83 more
Apr 24, 2017

Obesity, Diabetes, Hypertension Trial in Philadelphia (CHW Goal Support)

Completed
  • Obesity
  • +3 more
  • CHW Goal Support
  • Philadelphia, Pennsylvania
    University of Pennsylvania
May 2, 2017

Diabetes, Hypertension Trial in Philadelphia (Reminder, Fresh start, Fresh start framing)

Completed
  • Diabetes
  • Hypertension
  • Reminder
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
May 2, 2017

CHF, Diabetes, Renal Failure Trial in Philadelphia (Secure text messaging)

Withdrawn
  • Congestive Heart Failure
  • +3 more
  • Secure text messaging
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Apr 6, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Alexander City, Alabama
  • +135 more
Mar 8, 2017

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin detemir)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • Goodyear, Arizona
  • +68 more
Jan 30, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • insulin glargine
  • Litchfield Park, Arizona
  • +87 more
Jan 30, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +125 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, insulin detemir, metformin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alexander City, Alabama
  • +232 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Mexico, Puerto Rico, United States (liraglutide, glimepiride, )

Terminated
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +116 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Mesa, Arizona
  • +45 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Huntsville, Alabama
  • +115 more
Jan 20, 2017

Thrombospondin-1 and Pigmented Epithelium Derived Factor Levels

Completed
  • Diabetes
  • Diabetes Mellitus
  • Blood draw
  • Philadelphia, Pennsylvania
    Mid Atlantic Retina- Wills Eye Institute
Feb 17, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin aspart, insulin detemir)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin aspart
  • insulin detemir
  • Birmingham, Alabama
  • +66 more
Jan 2, 2017

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (repaglinide and metformin combination tablet, rosiglitazone and

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • repaglinide and metformin combination tablet
  • rosiglitazone and metformin combination tablet
  • Vestavia, Alabama
  • +102 more
Feb 9, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • insulin glargine
  • Greenbrae, California
  • +95 more
Jan 26, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin detemir, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin detemir
  • +2 more
  • Anaheim, California
  • +80 more
Jan 26, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • +2 more
  • Little Rock, Arkansas
  • +59 more
Jan 26, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Cypress, California
  • +19 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in United States (biphasic insulin aspart, pioglitazone, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • +2 more
  • Birmingham, Alabama
  • +72 more
Jan 10, 2017

Diabetes, Diabetes, Type 1 Trial in United States (insulin lispro, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin lispro
  • insulin aspart
  • Mobile, Alabama
  • +51 more
Dec 21, 2016